Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progressBusiness Insider • 08/04/21
BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MarylandBusiness Wire • 08/04/21
FDA expected to approve Pfizer-BioNTech's COVID-19 vaccine by early September: NYTBusiness Insider • 08/04/21
BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021GlobeNewsWire • 08/02/21
Worried About the Delta Variant? 5 Stocks to Insulate You From a COVID Market CrashThe Motley Fool • 08/01/21
Israel will roll out a booster dose of the Pfizer-BioNTech COVID-19 vaccine to older people, citing a drop in protection against severe disease driven by the Delta variantBusiness Insider • 07/29/21
Third Dose Of Pfizer-BioNTech's COVID-19 Vaccine Boosts Protection Against Delta Variant, New Data RevealsBenzinga • 07/28/21
Pfizer sells $7.8 billion in Covid shots in the Q2, raises 2021 guidance on vaccine salesCNBC • 07/28/21